Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,170 | N/A | -3,515 | -5,796 | -680 |
| Depreciation Amortization | 430 | N/A | 138 | 562 | 378 |
| Accounts receivable | -82 | N/A | 140 | 140 | 96 |
| Accounts payable and accrued liabilities | -135 | N/A | 629 | -175 | -580 |
| Other Working Capital | -810 | N/A | 389 | 271 | -805 |
| Other Operating Activity | -3,390 | 0 | -840 | -2,267 | -5,081 |
| Operating Cash Flow | $-8,157 | $N/A | $-3,059 | $-7,265 | $-6,672 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -403 | N/A | -6 | -836 | -566 |
| Investing Cash Flow | $-403 | $N/A | $-6 | $-836 | $-566 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,086 | N/A | N/A | 6,776 | N/A |
| Financing Cash Flow | $1,086 | $N/A | $N/A | $6,776 | $N/A |
| Exchange Rate Effect | -258 | N/A | -224 | -1,977 | -1,826 |
| Beginning Cash Position | 14,215 | N/A | 14,215 | 17,517 | 17,518 |
| End Cash Position | 6,484 | N/A | 10,926 | 14,215 | 8,447 |
| Net Cash Flow | $-7,732 | $N/A | $-3,289 | $-3,302 | $-9,064 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,157 | N/A | -3,059 | -7,265 | -6,672 |
| Capital Expenditure | -403 | N/A | -6 | -836 | -566 |
| Free Cash Flow | -8,560 | 0 | -3,065 | -8,101 | -7,238 |